Press Release

2025

Immumem Therapeutics Awarded $75,000 Non-Dilutive Grant Support to Advance Cell Therapy Development

2026

Immumem Therapeutics Featured in Unicorns Journal

Immumem Therapeutics Announces Backing from LvlUp Ventures to Eradicate Cancer Relapse Using AI-Driven, iPSC-Derived Cell Therapies